JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oxman, H. A.
Right arrow Articles by Ellis, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oxman, H. A.
Right arrow Articles by Ellis, F. H., Jr

The Journal of Thoracic and Cardiovascular Surgery, Vol 69, 247-254, Copyright © 1975 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Mitral valve replacement with the Smeloff-Cutter prosthesis. Experience with 154 patients and comparison with results of replacement with a Starr-Edwards prosthesis

HA Oxman, DC Connolly and FH Ellis Jr

Mitral valve replacement with the Smeloff-Cutter (S-C) prothesis was performed in 154 patients between September, 1965, and January, 1970. In 84, only the mitral valve was replaced; in the remainder, other valves were reconstructed or replaced. The hospital and late mortality rates for isolated replacement were 6 and 25 per cent, respectively. Comparable figures for the Starr-Edwards (S-E) (Models 6000 and 6120) prosthesis during this period were 11 and 23 per cent. Similar rates of thromboembolism were associated with the use of either prosthesis in surviving patients (27 per cent for the S-C valve and 30 per cent for the S-E valve). In spite of the acceptable hospital mortality rate for the S-C valve, it is not now considered suitable for clinical use because of the high late mortality rate and the high risk of thromboembolism that accompany its use.


This article has been cited by other articles:


Home page
 JAMAHome page
M. H. Eckman, J. R. Beshansky, I. Durand-Zaleski, H. J. Levine, and S. G. Pauker
Anticoagulation for Noncardiac Procedures in Patients With Prosthetic Heart Valves: Does Low Risk Mean High Cost?
JAMA, March 16, 1990; 263(11): 1513 - 1521.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. G. Montero, J. J. Rufilanchas, A. Juffe, R. Burgos, J. Ugarte, and D. Figuera
Long-Term Results of Cardiac Valve Replacement with the Delrin-Disc Model of the Bjork-Shiley Valve Prosthesis
Ann. Thorac. Surg., April 1, 1984; 37(4): 328 - 336.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. Daenen, A. Nevelsteen, P. van Cauwelaert, E. de Maesschalk, J. Willems, and G. Stalpaert
Nine Years' Experience with the Bjork-Shiley Prosthetic Valve: Early and Late Results of 932 Valve Replacements
Ann. Thorac. Surg., June 1, 1983; 35(6): 651 - 663.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
L. H. Edmunds Jr.
Thromboembolic Complications of Current Cardiac Valvular Prostheses
Ann. Thorac. Surg., July 1, 1982; 34(1): 96 - 106.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. H. Ellis Jr., R. W. Healy, and S. Alexander
Mitral Valve Replacement with the Modified University of Cape Town (UCT) Prosthesis: Clinical and Hemodynamic Results
Ann. Thorac. Surg., January 1, 1977; 23(1): 26 - 31.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1975 by The American Association for Thoracic Surgery.